Hanmi Pharm. Co., Ltd. 128940.KS Stock
307000 KRW
{{ price }}
-2.852615%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
South Korea
Exchange
KSE
Market Cap
3.9T KRW
LOW - HIGH [24H]
306000
-
314500 KRW
VOLUME [24H]
13.65K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
Hanmi Pharm. Co., Ltd. Price Chart
Hanmi Pharm. Co., Ltd. 128940.KS Financial and Trading Overview
| Hanmi Pharm. Co., Ltd. stock price | 307000 KRW |
| Previous Close | 313500 KRW |
| Open | 316000 KRW |
| Bid | 318500 KRW x 0 |
| Ask | 319500 KRW x 0 |
| Day's Range | 313000 - 324500 KRW |
| 52 Week Range | 219117.64 - 339500 KRW |
| Volume | 38.84K KRW |
| Avg. Volume | 51.99K KRW |
| Market Cap | 3.95T KRW |
| Beta (5Y Monthly) | 0.618493 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | 500 (0.14%) |
| Ex-Dividend Date | December 28, 2022 |
| 1y Target Est | 381569 KRW |
128940.KS Valuation Measures
| Enterprise Value | 4.58T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 1.72 |
| Price/Sales (ttm) | 2.8800085 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3.34 |
| Enterprise Value/EBITDA | 16.867 |
Trading Information
Hanmi Pharm. Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.618493 |
| 52-Week Change | 10.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 339500 KRW |
| 52 Week Low | 219117.64 KRW |
| 50-Day Moving Average | 310550 KRW |
| 200-Day Moving Average | 273377.66 KRW |
128940.KS Share Statistics
| Avg. Volume (3 month) | 51.99K KRW |
| Avg. Daily Volume (10-Days) | 48.14K KRW |
| Shares Outstanding | 12.44M |
| Float | 6.27M |
| Short Ratio | N/A |
| % Held by Insiders | 49.02% |
| % Held by Institutions | 19.56% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | 16.00% |
| Payout Ratio | 0.0583 |
| Last Split Factor | 1.02:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.75% |
| Operating Margin (ttm) | 12.60% |
| Gross Margin | 54.89% |
| EBITDA Margin | 19.80% |
Management Effectiveness
| Return on Assets (ttm) | 5.44% |
| Return on Equity (ttm) | 12.52% |
Income Statement
| Revenue (ttm) | 1.37T KRW |
| Revenue Per Share (ttm) | 110156.88 KRW |
| Quarterly Revenue Growth (yoy) | 12.50% |
| Gross Profit (ttm) | 718.55B KRW |
| EBITDA | 271.63B KRW |
| Net Income Avi to Common (ttm) | 106.42B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 121.10% |
Balance Sheet
| Total Cash (mrq) | 318.21B KRW |
| Total Cash Per Share (mrq) | 25575.77 KRW |
| Total Debt (mrq) | 682.66B KRW |
| Total Debt/Equity (mrq) | 63.9 KRW |
| Current Ratio (mrq) | 1.125 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 142.46B KRW |
| Levered Free Cash Flow (ttm) | 167.62B KRW |
Profile of Hanmi Pharm. Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 14, Wiryeseong-daero |
| ZIP | 05545 |
| Phone | 82 2 410 9114 |
| Website | https://www.hanmipharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 2240 |
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Q&A For Hanmi Pharm. Co., Ltd. Stock
What is a current 128940.KS stock price?
Hanmi Pharm. Co., Ltd. 128940.KS stock price today per share is 307000 KRW.
How to purchase Hanmi Pharm. Co., Ltd. stock?
You can buy 128940.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hanmi Pharm. Co., Ltd.?
The stock symbol or ticker of Hanmi Pharm. Co., Ltd. is 128940.KS.
Which industry does the Hanmi Pharm. Co., Ltd. company belong to?
The Hanmi Pharm. Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hanmi Pharm. Co., Ltd. have in circulation?
The max supply of Hanmi Pharm. Co., Ltd. shares is 12.69M.
What is Hanmi Pharm. Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hanmi Pharm. Co., Ltd. PE Ratio is now.
What was Hanmi Pharm. Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hanmi Pharm. Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Hanmi Pharm. Co., Ltd. company belong to?
The Hanmi Pharm. Co., Ltd. sector is Healthcare.